Pharmacare Premium Ltd., Remedica Ltd, STADA Arzneimittel AG

Poland

All drugs from this manufacturer

  • SUNITINIB STADA

    The medicine is used in adult patients for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma, and pancreatic neuroendocrine tumors.

    Dosage form: capsules, hard

    Active substance Dosage
    sunitinib 12.5 mg

    ATC: L01EX01

  • SUNITINIB STADA

    The medicine is used in adult patients for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET).

    Dosage form: capsules, hard

    Active substance Dosage
    sunitinib 25 mg

    ATC: L01EX01

  • SUNITINIB STADA

    The medicine is used in adult patients for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma, and pancreatic neuroendocrine tumors (pNET).

    Dosage form: capsules, hard

    Active substance Dosage
    sunitinib 37.5 mg

    ATC: L01EX01

  • SUNITINIB STADA

    The medicinal product is used in adult patients for the treatment of cancers: gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET).

    Dosage form: capsules, hard

    Active substance Dosage
    sunitinib 50 mg

    ATC: L01EX01